Do you have the same question? Follow this Question
Mar 16, 2026 - 11:20 AM
We’ve provided several answers to questions related to Asmanex HFA (Mometasone) , see some other helpful Q&A related to this product.
Question: What is the MedlinePlus reference for this medication?
Answer: The MedlinePlus code is a687014. MedlinePlus provides patient-friendly information about medications, supporting safe use.
Question: What is the DrugBank identifier for this medication?
Answer: The DrugBank ID is DB00764. DrugBank identifiers are useful for researchers and healthcare professionals looking for detailed drug data.
Question: What brands is this medication sold under?
Answer: It is sold under the brand name Asmanex. Branding can help patients and providers quickly identify the correct product.
Question: What is the route of administration for this inhaler?
Answer: The route of administration is inhalation via a nasal spray. Inhalation delivers medication directly to the lungs, which is beneficial for treating asthma.
Question: What is the chemical name of the active ingredient?
Answer: The chemical name is mometasone. Understanding the chemical name is important for recognizing the drug in medical literature and prescriptions.
Question: What is the recommended dose for children between 5 and 11 years old?
Answer: For children aged 5 to 11 years, the recommended dose is 2 puffs by mouth twice a day of the 50 mcg strength. Lower strength dosing in younger children helps minimize side effects while managing symptoms.
Question: How many doses are there in each inhaler?
Answer: Each inhaler contains 120 doses. A higher number of doses per inhaler means less frequent refills and greater convenience for users.
